These things baffle me, what appears to have potential for multi billion $$ market cap trading at $22m, why doesn't the market believe? (BDX is another I have been keeping an eye on for quite some time now where something seems wrong just because the market is pricing it so cheaply)
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark, page-49
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.010(2.44%) |
Mkt cap ! $32.64M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.0¢ | 39.0¢ | $35.70K | 89.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 765 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| COV (ASX) Chart |